🤖 GLOBAL HEALTH OPTIMIZATION AGENT v3.0

🔬 Current Disease Focus:

Task Progress: 0%

👥 Active Problem Solvers

🌍 Experts collaborating globally

⚡ Current Task Assignment

🧬 Genetic Analysis

🔄 Matching experts to specific tasks

📊 Resource Allocation by Research Phase:

📚 Data Analysis

🧪 Experimental Design

🔬 Clinical Trials

💊 Treatment Development

Trial Search

Current Search Criteria:

Intervention: administration of Cimzia®

Found 15 matching trials

Efficacy of Re-treatment With Cimzia® in Subject With Chronic Plaque Psoriasis

PHASE2

The primary objective is to assess differences in PASI scores between Week ...

Status

Completed

Location

Multiple Locations

Start Date

2006-04

Trial ID

NCT00329303

Treatments Being Tested

Certolizumab Pegol (Cimzia®)

A Multicener, Postmarketing Study Evaluating the Transfer of Cimzia From the Mother to the Infant Via the Placenta

PHASE1

The primary purpose is to assess whether there is transfer of Certolizumab ...

Status

Completed

Location

Start Date

2014-01

Trial ID

NCT02019602

Treatments Being Tested

Blood sampling from mother Blood sampling from infant Blood sampling from umbilical cord Certolizumab Pegol

Noninterventional Examination of Subcutaneous (sc) Tumor Necrosis Factor (TNF) Inhibitors

N/A

This prospective, post marketing, observational, Noninterventional Study (N...

Status

Completed

Location

039

Start Date

2012-12

Trial ID

NCT01764321

RABIOPRED - a Validation Study of Theranostic Test to PREDict Treatment Response of Anti-TNFα BIologicals in Rheumatoid Arthritis

N/A

RABIOPRED is an in vitro non-invasive blood test, which aims to identify pa...

Status

Terminated

Location

Institute of Rheumatology

Start Date

2016-12

Trial ID

NCT03016260

Treatments Being Tested

Infliximab Adalimumab Etanercept Golimumab Certolizumab Pegol Infliximab biosimilar Etanercept biosimilar Infliximab biosimilar

IL-7 and IL-7R Expression in RA Patients With Active vs. Inactive Disease Treated With DMARD or CIMZIA

PHASE4

The purpose of the study is to better understand the factors present in the...

Status

Completed

Location

Outpatient Care Center

Start Date

2015-08

Trial ID

NCT02451748

Treatments Being Tested

Lab Work Certolizumab pegol (CDP870, tradename Cimzia)(prefilled syringes at the dose of 200mg)Certolizumab pegol (CDP870, tradename Cimzia)Hydroxychloroquine Sulfasalazine Medrol Prednisone Triamcinolone Naproxen Leflunomide Methotrexate humira

SECURE, the Cimzia ® Crohn's Disease Post-Marketing Registry

N/A

The purpose of this study is to monitor safety outcomes of patients who hav...

Status

Completed

Location

C87075 931

Start Date

2009-01-30

Trial ID

NCT00844285

Treatments Being Tested

Cimzia

RETRO (REduction of Therapy in RA Patients in Ongoing Remission)

PHASE3

This is a phase 3, multicenter, randomized, open, prospective, controlled, ...

Status

Unknown

Location

Asklepios Klinikum Bad Abbach

Start Date

2009-01

Trial ID

NCT02779114

Treatments Being Tested

Control group Reduction group 1 Reduction group 2

The Use of Certolizumab Pegol for Treatment of Active Crohn's Disease in Children and Adolescents

PHASE2

The purpose of this study is to evaluate the safety, efficacy, pharmacokine...

Status

Terminated

Location

Multiple Locations

Start Date

2009-04

Trial ID

NCT00899678

Treatments Being Tested

Certolizumab Pegol Certolizumab Pegol

SKIN Disease Profiling by an Exploratory, pRospective, Biomarker Study in dermatoloGY Practice (SKINERGY)

N/A

The goal of this observational study is to comprehensively profile six immu...

Status

Recruiting

Location

Radboud University Medical Center

Start Date

2025-07-29

Trial ID

NCT07021495

A Multicenter, Postmarketing Study Evaluating the Concentration of Cimzia® in Mature Breast Milk of Lactating Mothers

PHASE1

The primary objectives of this study are to assess whether there is transfe...

Status

Completed

Location

Start Date

2014-09

Trial ID

NCT02154425

Treatments Being Tested

Breast milk sampling Certolizumab Pegol

Previous Next